Trial in Progress: PRESTIGE—Primary Retroperitoneal Lymph Node Dissection (RPLND) for Clinical Stage II (CSII) Testicular Germ Cell Tumour (TGCT) and Its Impact on Health-Related Quality of Life (hrqol) Compared to Chemotherapy or Radiotherapy.
Journal of Clinical Oncology（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要